These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 21708014
1. Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis. Lee EY, Seo M, Juhnn YS, Kim JY, Hong YJ, Lee YJ, Lee EB, Song YW. Arthritis Res Ther; 2011 Jun 27; 13(3):R104. PubMed ID: 21708014 [Abstract] [Full Text] [Related]
2. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N. Arthritis Rheum; 2001 May 27; 44(5):1003-12. PubMed ID: 11352231 [Abstract] [Full Text] [Related]
3. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis. Kim HR, Kim KW, Kim BM, Jung HG, Cho ML, Lee SH. Arthritis Rheumatol; 2014 Mar 27; 66(3):538-48. PubMed ID: 24574213 [Abstract] [Full Text] [Related]
5. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Hashizume M, Hayakawa N, Mihara M. Rheumatology (Oxford); 2008 Nov 27; 47(11):1635-40. PubMed ID: 18786965 [Abstract] [Full Text] [Related]
6. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis. Tsushima H, Okazaki K, Ishihara K, Ushijima T, Iwamoto Y. Arthritis Res Ther; 2015 Feb 17; 17(1):31. PubMed ID: 25811130 [Abstract] [Full Text] [Related]
9. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Kim KW, Cho ML, Oh HJ, Kim HR, Kang CM, Heo YM, Lee SH, Kim HY. Immunol Lett; 2009 May 14; 124(1):9-17. PubMed ID: 19446344 [Abstract] [Full Text] [Related]
10. Efficacy of novel bispecific antibody targeting TNF-α/CXCL10 in the treatment of experimental arthritis. Kang SE, Park JK, Yoo HJ, Kang HS, Park YW, Park BC, Park JE, Lee EY, Lee EB, Song YW. Transl Res; 2021 Jun 14; 232():75-87. PubMed ID: 33453429 [Abstract] [Full Text] [Related]
12. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Autoimmun Rev; 2014 Mar 14; 13(3):272-80. PubMed ID: 24189283 [Abstract] [Full Text] [Related]
13. Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis. Wen H, Liu Y, Li J, Wei D, Liu D, Zhao F. Clin Exp Rheumatol; 2018 Mar 14; 36(5):798-805. PubMed ID: 29465363 [Abstract] [Full Text] [Related]
14. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis. Kim KW, Kim HR, Kim BM, Cho ML, Lee SH. Am J Pathol; 2015 Nov 14; 185(11):3011-24. PubMed ID: 26362732 [Abstract] [Full Text] [Related]
15. Sphingosine 1-phosphate (S1P)/S1P receptor 1 signaling regulates receptor activator of NF-κB ligand (RANKL) expression in rheumatoid arthritis. Takeshita H, Kitano M, Iwasaki T, Kitano S, Tsunemi S, Sato C, Sekiguchi M, Azuma N, Miyazawa K, Hla T, Sano H. Biochem Biophys Res Commun; 2012 Mar 09; 419(2):154-9. PubMed ID: 22326262 [Abstract] [Full Text] [Related]
16. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Kim HR, Kim KW, Jung HG, Yoon KS, Oh HJ, Cho ML, Lee SH. Arthritis Res Ther; 2011 Mar 14; 13(2):R43. PubMed ID: 21401926 [Abstract] [Full Text] [Related]
17. Recombinant human endostatin inhibits TNF-alpha-induced receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes in mice with adjuvant arthritis. Gao QF, Zhang XH, Yuan FL, Zhao MD, Li X. Cell Biol Int; 2016 Dec 14; 40(12):1340-1348. PubMed ID: 27730697 [Abstract] [Full Text] [Related]
18. Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis. Meednu N, Zhang H, Owen T, Sun W, Wang V, Cistrone C, Rangel-Moreno J, Xing L, Anolik JH. Arthritis Rheumatol; 2016 Apr 14; 68(4):805-16. PubMed ID: 26554541 [Abstract] [Full Text] [Related]
19. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways. Li X, Kim KW, Cho ML, Ju JH, Kang CM, Oh HJ, Min JK, Lee SH, Park SH, Kim HY. Immunol Lett; 2010 Jan 04; 127(2):100-7. PubMed ID: 19900478 [Abstract] [Full Text] [Related]
20. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis. Lee HY, Jeon HS, Song EK, Han MK, Park SI, Lee SI, Yun HJ, Kim JR, Kim JS, Lee YC, Kim SI, Kim HR, Choi JY, Kang I, Kim HY, Yoo WH. Arthritis Rheum; 2006 Jun 04; 54(6):1747-58. PubMed ID: 16736517 [Abstract] [Full Text] [Related] Page: [Next] [New Search]